Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial [Hot Topic: Hydrogen Sulfide: From Molecular Biology to Pharmacology Guest Editor: Stefano Fiorucci)]
Volume: 10 Issue: 2
Author(s): Stefano Fiorucci
Affiliation:
Export Options
About this article
Cite this article as:
Fiorucci Stefano, Editorial [Hot Topic: Hydrogen Sulfide: From Molecular Biology to Pharmacology Guest Editor: Stefano Fiorucci)], Inflammation & Allergy - Drug Targets (Discontinued) 2011; 10 (2) . https://dx.doi.org/10.2174/187152811794776259
DOI https://dx.doi.org/10.2174/187152811794776259 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
15
Related Articles
-
Drug-Metabolizing Enzymes Mechanisms and Functions
Current Drug Metabolism An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
Current Topics in Medicinal Chemistry Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates
Anti-Cancer Agents in Medicinal Chemistry Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment
Recent Patents on Anti-Cancer Drug Discovery Gap Junctions as Therapeutic Targets in Brain Injury Following Hypoxia- Ischemia
Recent Patents on CNS Drug Discovery (Discontinued) Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: The Triumph of Radiobiology
Reviews on Recent Clinical Trials Radiotracers in Oncology
Current Radiopharmaceuticals HSP60 as a Drug Target
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Medicinal Chemistry Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor
Recent Patents on Anti-Cancer Drug Discovery Current and Next Generation Topical Anti-Skin Cancer Therapeutics
Drug Delivery Letters Androgen Receptor in Human Health: A Potential Therapeutic Target
Current Drug Targets Molecular Foundations for Personalized Therapy in Prostate Cancer
Current Drug Targets